Robert J. Valuck

Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs

Anne M. Libby, David A. Brent, Elaine H. Morrato et al. · American Journal of Psychiatry · 2007 · 278 citations

Pharmacy, Pediatrics, Pharmacotherapy +17

Multiple sclerosis prevalence in the United States commercially insured population

Piyameth Dilokthornsakul, Robert J. Valuck, Kavita Nair et al. · Neurology · 2016 · 278 citations · Full text

Medicine, Insurance, Neurology +12

A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults

Robert J. Valuck, J. Mark Ruscin · Journal of Clinical Epidemiology · 2004 · 238 citations

Public Health, Geriatric Medicine, Pharmacotherapy +15

Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs

Elaine H. Morrato, Benjamin G. Druss, Daniel M. Hartung et al. · Archives of General Psychiatry · 2010 · 201 citations

Pharmacy, Pharmaceutical Policy, Pharmacotherapy +16

Antidepressant Treatment and Risk of Suicide Attempt by Adolescents with Major Depressive Disorder

Robert J. Valuck, Anne M. Libby, Marion R. Sills et al. · CNS Drugs · 2004 · 186 citations

Medicine, Psychiatry, Psychology +16